<DOC>
	<DOCNO>NCT00537641</DOCNO>
	<brief_summary>This study test hypothesis noninvasive ventilation ( NIV ) prescribe current medical practice use amyotrophic Lateral Sclerosis ( ALS ) patient fail deliver adequate breathing support night use patient 's home . ALS patient come ALS Center routine 3 month follow exam currently use NIV ask complete questionnaire regard quality sleep , quality life general level function , undergo home sleep study , use safe , comfortable reliable breathe monitoring system night sleep . If questionnaire sleep study show failure breathe device , investigator work patient fix problem offer second study make sure change helpful . The result study may help develop subsequent study improve guideline use care ALS patient .</brief_summary>
	<brief_title>Efficacy Noninvasive Ventilation Amyotrophic Lateral Sclerosis ( ALS )</brief_title>
	<detailed_description>Amyotrophic Lateral Sclerosis ( ALS ) , also know `` Lou Gehrig 's Disease '' , fatal disorder cause breathing failure due progressive weakness muscle breathe . Breathing assist device know noninvasive ventilation ( NIV ) offer ALS patient breathe function worsens . These device deliver breathe assistance via mask nose nose mouth , think particularly important use sleep , breathe often become shallow irregular . However , although device become standard therapy ALS patient lung function worsens , remain unclear effective device actually patient sleeping , partly practical difficulty apply device properly keep apply throughout sleep period , partly commonly prescribe without objective evidence regard much breathing support patient need disease progress breathe muscle weaken .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>clinical diagnosis amyotrophic lateral sclerosis ( El Escorial criterion ) age 18 18 year old use nocturnal noninvasive ventilation treat respiratory insufficiency least 4 hour per night , least 4 night per week inability safely use NIPPV bulbar dysfunction indication tracheostomy assist ventilation due inability clear secretion airway presence comorbid condition life expectancy &lt; 6 month presence advance dementia unwillingness follow Eleanor Lou Gehrig ALS/MDA Center Columbia University regular basis previously diagnose obstructive sleep apnea residence outside New York metropolitan area .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>noninvasive ventilation</keyword>
</DOC>